Carbon assimilation profiles as a tool for identification of Zygomycetes

被引:32
作者
Schwarz, Patrick
Lortholary, Olivier
Dromer, Francoise
Dannaoui, Eric
机构
[1] Inst Pasteur, Ctr Natl Reference Mycol & Antifongiques, Unite Mycol Mol, CNRS,URA3012, F-75724 Paris 15, France
[2] Univ Paris 05, Fac Med, AP HP, Hop Necker Enfants Malad,Serv Malad Infect & Trop, F-75743 Paris 15, France
[3] Univ Paris 05, Fac Med, AP HP, Hop Europeen Georges Pompidou,Unite Parasitol Myc, F-75015 Paris, France
关键词
D O I
10.1128/JCM.02219-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Identification of Zygomycetes is difficult and time-consuming by standard microbiological procedures. Carbon assimilation profiles are commonly used for yeast-and bacterial-species identification but rarely for filamentous-fungus identification. Carbon assimilation profiles were evaluated using the commercialized kits ID32C and API 50 CH, which contain 31 and 49 tests, respectively, to serve as simple tools for species identification of Zygomycetes in clinical microbiology laboratories. Fifty-seven strains belonging to 15 species and varieties of Zygomycetes, including Rhizopus, Absidia, Mucor, and Rhizomucor species, were tested for intra- and interspecies variability based on their carbon assimilation profiles. Using ID32C strips, 6 tests were always positive, 7 were never positive, and 18 showed consistently different results between species. With API 50 CH strips, 15 tests were positive for all species, 13 were never positive, and 21 showed different results between species. Nevertheless, assimilation patterns were highly variable among Rhizopus oryzae isolates, and it was not possible to define a specific carbon assimilation profile. With both ID32C and API CH 50 strips, intraspecies variation was found to be low, while large differences were found between genera and species. The clustering of isolates based on their carbon assimilation profiles was in accordance with DNA-based phylogeny of Zygomycetes. In conclusion, carbon assimilation profiles allowed precise and accurate identification of most Zygomycetes to the species level.
引用
收藏
页码:1433 / 1439
页数:7
相关论文
共 36 条
[1]   RDNA ITS sequence of Rhizopus oryzae:: Its application to classification and identification of lactic acid producers [J].
Abe, A ;
Sone, T ;
Sujaya, IN ;
Saito, K ;
Oda, Y ;
Asano, K ;
Tomita, F .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2003, 67 (08) :1725-1731
[2]  
Barnett J.A., 2000, YEASTS CHARACTERISTI
[3]   Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi [J].
Cuenca-Estrella, M ;
Gomez-Lopez, A ;
Mellado, E ;
Buitrago, MJ ;
Monzon, A ;
Rodriguez-Tudela, JL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :917-921
[4]   In vitro susceptibilities of Zygomycota to polyenes [J].
Dannaoui, E ;
Meis, JFGM ;
Mouton, JW ;
Verweij, PE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 49 (05) :741-744
[5]   In vitro susceptibilities of zygomycetes to conventional and new antifungals [J].
Dannaoui, E ;
Meletiadis, J ;
Mouton, JW ;
Meis, JFGM ;
Verweij, PE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) :45-52
[6]  
de Hoog GS, 1995, Atlas of clinical fungi, V1st
[7]   Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :2950-2956
[8]   Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation [J].
Girmenia, C ;
Moleti, ML ;
Micozzi, A ;
Iori, AP ;
Barberi, W ;
Foà, R ;
Martino, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (10) :5395-5396
[9]   Posaconazole as salvage therapy for zygomycosis [J].
Greenberg, RN ;
Mullane, K ;
van Burik, JAH ;
Raad, I ;
Abzug, MJ ;
Anstead, G ;
Herbrecht, R ;
Langston, A ;
Marr, KA ;
Schiller, G ;
Schuster, M ;
Wingard, JR ;
Gonzalez, CE ;
Revankar, SG ;
Corcoran, G ;
Kryscio, RJ ;
Hare, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :126-133
[10]   Zygomycosis (mucormycosis): emerging clinical importance and new treatments [J].
Greenberg, RN ;
Scott, LJ ;
Vaughn, HH ;
Ribes, JA .
CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (06) :517-525